We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+16.98%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$295B
AUM Growth
+$35.4B
Cap. Flow
-$1.58B
Cap. Flow %
-0.53%
Top 10 Hldgs %
22.42%
Holding
3,425
New
145
Increased
1,798
Reduced
1,253
Closed
125

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1B
2
AAPL icon
Apple
AAPL
+$797M
3
MRK icon
Merck
MRK
+$316M
4
AMZN icon
Amazon
AMZN
+$308M
5
MDT icon
Medtronic
MDT
+$298M

Sector Composition

Rank Sector Weight
1 Technology 24.73%
2 Healthcare 13.29%
3 Consumer Discretionary 13.23%
4 Financials 12.2%
5 Communication Services 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UHT
2151
Universal Health Realty Income Trust
UHT
$594M
$4.1M ﹤0.01%
52,721
-2,021
-4% -$123K
PAE
2152
DELISTED
PAE Incorporated Class A Common Stock
PAE
$4.08M ﹤0.01%
444,845
+52,887
+13% +$489K
KNL
2153
DELISTED
Knoll, Inc.
KNL
$4.08M ﹤0.01%
278,240
+55,273
+25% +$746K
FIZZ icon
2154
National Beverage
FIZZ
$3.01B
$4.07M ﹤0.01%
95,800
-1,982
-2% -$85.2K
SNDR icon
2155
Schneider National
SNDR
$6.25B
$4.05M ﹤0.01%
195,745
-78,083
-29% -$1.75M
HA
2156
DELISTED
Hawaiian Holdings, Inc.
HA
$4.05M ﹤0.01%
228,791
+565
+0.2% +$9.57K
IIIV icon
2157
i3 Verticals
IIIV
$342M
$4.05M ﹤0.01%
121,923
+64,534
+112% +$1.73M
ALXO icon
2158
ALX Oncology
ALXO
$290M
$4.04M ﹤0.01%
46,905
+10,997
+31% +$662K
GFF icon
2159
Griffon
GFF
$4.86B
$4.04M ﹤0.01%
198,239
+8,135
+4% +$175K
LUNG icon
2160
Pulmonx
LUNG
$87.6M
$4.03M ﹤0.01%
+58,343
New +$2.86M
LGF.B
2161
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$4.03M ﹤0.01%
387,775
-29,627
-7% -$246K
RYTM icon
2162
Rhythm Pharmaceuticals
RYTM
$7.96B
$4.02M ﹤0.01%
135,106
+15,447
+13% +$393K
XPEL icon
2163
XPEL
XPEL
$1.38B
$4.01M ﹤0.01%
77,778
-1,222
-2% -$44.2K
CTMX icon
2164
CytomX Therapeutics
CTMX
$754M
$4M ﹤0.01%
610,396
-20,523
-3% -$147K
MNKD icon
2165
MannKind Corp
MNKD
$1.32B
$3.99M ﹤0.01%
1,275,900
+489,627
+62% +$1.28M
TD icon
2166
Toronto Dominion Bank
TD
$200B
$3.99M ﹤0.01%
70,646
-24,028
-25% -$1.22M
STRL icon
2167
Sterling Infrastructure
STRL
$16.7B
$3.98M ﹤0.01%
213,714
-71,919
-25% -$1.17M
EPZM
2168
DELISTED
Epizyme, Inc
EPZM
$3.97M ﹤0.01%
365,556
-39,745
-10% -$490K
LU icon
2169
Lufax Holding
LU
$1.3B
$3.96M ﹤0.01%
+69,697
New +$4.17M
AHCO icon
2170
AdaptHealth
AHCO
$759M
$3.95M ﹤0.01%
105,256
+8,151
+8% +$252K
UEIC icon
2171
Universal Electronics
UEIC
$61.3M
$3.95M ﹤0.01%
75,311
-5,663
-7% -$261K
LBTYK icon
2172
Liberty Global Class C
LBTYK
$3.49B
$3.94M ﹤0.01%
166,571
-62,770
-27% -$1.36M
VECO icon
2173
Veeco
VECO
$3.23B
$3.94M ﹤0.01%
226,886
+8,194
+4% +$125K
SNR
2174
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
$3.93M ﹤0.01%
414,896
+6,588
+2% +$32.2K
CEVA icon
2175
CEVA Inc
CEVA
$1.08B
$3.93M ﹤0.01%
86,302
+251
+0.3% +$10.3K

Similar funds

Nuveen's Q4 2020 Portfolio in Review

As of Q4 2020, Nuveen held 3,425 positions worth $295B, up 14% from $260B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Nuveen's Q4 2020 filing shows 145 new, 1,798 increased, 1,253 reduced and 125 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M. The largest sale was Walt Disney, an estimated $587M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Nuveen's largest Q4 2020 buy was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M.
  • Nuveen added most to Microsoft in Q4 2020, an estimated $1B increase.
  • Nuveen's biggest Q4 2020 reduction was Walt Disney, cutting an estimated $587M.
  • Nuveen fully exited Alcon in Q4 2020, selling an estimated $174M.
  • Nuveen's ten largest holdings make up 22% of its $295B portfolio in Q4 2020.
  • Nuveen opened 145 new positions and closed 125 in Q4 2020.
  • Nuveen's portfolio value rose 14% quarter-over-quarter to $295B.

Based on Nuveen's 13F filing for Q4 2020, filed 16 Feb 2021.